Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $31,054 | 49 | 34.5% |
| Honoraria | $28,850 | 9 | 32.0% |
| Unspecified | $10,100 | 5 | 11.2% |
| Consulting Fee | $8,898 | 6 | 9.9% |
| Food and Beverage | $8,047 | 210 | 8.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,676 | 2 | 1.9% |
| Education | $1,463 | 15 | 1.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Octapharma USA, Inc. | $62,541 | 115 | $0 (2023) |
| Shire North American Group Inc | $20,604 | 43 | $0 (2019) |
| PFIZER INC. | $2,653 | 12 | $0 (2024) |
| CSL Behring | $1,443 | 32 | $0 (2023) |
| GlaxoSmithKline, LLC. | $351.96 | 19 | $0 (2021) |
| Grifols USA, LLC | $333.52 | 8 | $0 (2024) |
| Horizon Therapeutics plc | $326.01 | 11 | $0 (2023) |
| Grifols Shared Services North America, Inc. | $281.12 | 4 | $0 (2023) |
| Genentech, Inc. | $249.75 | 3 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $175.30 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,004 | 3 | PFIZER INC. ($740.00) |
| 2023 | $5,025 | 24 | Octapharma USA, Inc. ($4,627) |
| 2022 | $20,594 | 16 | Octapharma USA, Inc. ($20,279) |
| 2021 | $9,481 | 40 | Octapharma USA, Inc. ($7,361) |
| 2020 | $1,667 | 27 | Octapharma USA, Inc. ($1,088) |
| 2019 | $11,949 | 60 | Octapharma USA, Inc. ($10,911) |
| 2018 | $32,010 | 84 | Octapharma USA, Inc. ($17,944) |
| 2017 | $8,357 | 42 | Shire North American Group Inc ($7,299) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $149.88 | General |
| Category: Immunology and Neurology | ||||||
| 02/25/2024 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $114.33 | General |
| Category: APDS | ||||||
| 01/30/2024 | PFIZER INC. | PAXLOVID (Drug) | Consulting Fee | Cash or cash equivalent | $740.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/01/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | — | Cash or cash equivalent | $1,300.00 | Research |
| Study: SCGAM-06 • Category: IMMUNOLOGY | ||||||
| 10/26/2023 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $70.07 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $60.08 | General |
| 08/24/2023 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $66.98 | General |
| Category: Immunology | ||||||
| 08/16/2023 | Grifols Shared Services North America, Inc. | Xembify (Biological) | Food and Beverage | In-kind items and services | $99.86 | General |
| Category: Immunology and Neurology | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Travel and Lodging | Cash or cash equivalent | $163.20 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Education | Cash or cash equivalent | $56.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | Cash or cash equivalent | $27.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | Cash or cash equivalent | $26.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Education | Cash or cash equivalent | $23.58 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $58.49 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Education | Cash or cash equivalent | $84.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Travel and Lodging | Cash or cash equivalent | $48.50 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Travel and Lodging | Cash or cash equivalent | $45.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Education | Cash or cash equivalent | $26.20 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Education | Cash or cash equivalent | $10.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | Cash or cash equivalent | $4.06 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2023 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $142.54 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SCGAM-03 | Octapharma USA, Inc. | $5,800 | 2 |
| SCGAM-06 | Octapharma USA, Inc. | $4,300 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 8 | 345 | 2,428 | $159,593 | $73,837 |
| 2020 | 8 | 319 | 620 | $70,128 | $21,068 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2021 | 15 | 1,695 | $78,750 | $46,693 | 59.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 117 | 208 | $36,400 | $13,010 | 35.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 113 | $28,250 | $10,309 | 36.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 38 | 175 | $5,794 | $1,262 | 21.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 34 | 37 | $2,775 | $808.82 | 29.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 76 | $3,800 | $766.08 | 20.2% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 20 | 99 | $2,574 | $626.04 | 24.3% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2021 | 23 | 25 | $1,250 | $362.75 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 124 | 191 | $30,880 | $9,852 | 31.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 90 | $21,500 | $6,860 | 31.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $4,780 | $1,663 | 34.8% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 37 | 148 | $4,895 | $898.24 | 18.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 73 | $3,650 | $664.31 | 18.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 26 | 29 | $2,131 | $557.98 | 26.2% |
| 95012 | Measurement of inhaled nitric oxide gas | Office | 2020 | 19 | 23 | $940.00 | $287.88 | 30.6% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 18 | 52 | $1,352 | $284.74 | 21.1% |
About Dr. Roger Kobayashi, M.D
Dr. Roger Kobayashi, M.D is a Allergy & Immunology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093707754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Kobayashi, M.D has received a total of $90,088 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 296 transactions from 29 companies. The most common payment nature is "Travel and Lodging" ($31,054).
As a Medicare-enrolled provider, Kobayashi has provided services to 664 Medicare beneficiaries, totaling 3,048 services with total Medicare billing of $94,905. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Omaha, NE
- Active Since 08/18/2005
- Last Updated 06/30/2011
- Taxonomy Code 207K00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093707754
Products in Payments
- CUTAQUIG (Biological) $28,600
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $14,928
- CUTAQUIQ (Biological) $11,893
- HYQVIA (Biological) $6,673
- OCTANORM (Biological) $5,800
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $1,723
- Hizentra (Biological) $1,063
- CUVITRU (Biological) $858.95
- PAXLOVID (Drug) $740.00
- OCTAGAM (Biological) $582.61
- Xembify (Biological) $436.07
- ACTIMMUNE (Drug) $349.43
- NUCALA (Biological) $301.79
- Xofluza (Drug) $249.75
- Gamunex-C (Biological) $178.57
- XOLAIR (Biological) $153.26
- Zemaira (Biological) $151.78
- AMZEEQ (Drug) $124.99
- CINRYZE (Drug) $118.82
- JOENJA (Drug) $114.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Omaha
Mr. James Tracy, D.o, D.O
Allergy & Immunology — Payments: $71,068
Dr. Jeffrey Nelson, M.d, M.D
Allergy & Immunology — Payments: $11,626
Dr. Teodoro Segura, Md, Phd, MD, PHD
Allergy & Immunology — Payments: $10,273
Sara May, M.d, M.D
Allergy & Immunology — Payments: $2,039
Joel Van De Graaff, M.d, M.D
Allergy & Immunology — Payments: $824.75
Jill Poole, Md, MD
Allergy & Immunology — Payments: $435.69